America February 23, 2026
Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
America February 23, 2026
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
By Rihem Akkouche
America October 22, 2025
In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that it will acquire…
By Rihem Akkouche
America September 29, 2025
In a high-stakes gamble that could reshape the oncology landscape, Danish biotechnology powerhouse Genmab AS announced Monday it will acquire…
By Rihem Akkouche
America July 10, 2025
In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…
By Rihem Akkouche
America June 12, 2025
In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…
By Rihem Akkouche
America March 17, 2025
In a high-stakes move set to reshape the biotech landscape, Taiho Pharmaceutical Co. Ltd. announced Monday that it will acquire…
By Rihem Akkouche
America March 5, 2025
In a move set to reshape the oncology market, Jazz Pharmaceuticals announced Wednesday its plans to acquire Chimerix in a…
By Rihem Akkouche
America February 24, 2025
Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…
By Rihem Akkouche
America February 7, 2024
Biotechnology innovator Redx Pharma PLC announced a groundbreaking agreement on Wednesday, entailing the transfer of global rights for the advancement…
By Rihem Akkouche
America February 6, 2024
In a strategic move to bolster its oncology treatment options, Novartis AG, the Swiss pharmaceutical juggernaut, has inked a monumental…
By Rihem Akkouche